Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer

Journal of Urology

Volumn 191, Issue 2, 2014, Pages 350-357

  Vellekoop, Annelies ^a   Loeb, Stacy ^a   Folkvaljon, Yasin ^c,d   Stattin, Pär ^b,d  

^a NEW YORK UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

neoplasm grading; pathology; prognosis; prostatic neoplasms; watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; CANCER EPIDEMIOLOGY; CLINICAL PROTOCOL; COHORT ANALYSIS; DENSITY; PATIENT SELECTION; TUMOR BIOPSY;

ACTIVE SURVEILLANCE; AS; GLEASON SCORE; GS; NEOPLASM GRADING; PATHOLOGY; PCA; PROGNOSIS; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSA; PSA DENSITY; PSAD; RADICAL PROSTATECTOMY; RP; WATCHFUL WAITING;

HUMANS; LOGISTIC MODELS; MALE; NEOPLASM GRADING; ORGAN SIZE; POPULATION SURVEILLANCE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SWEDEN; WATCHFUL WAITING;

EID: 84891938861     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.09.034     Document Type: Article

References (30)

1. J.I. Epstein, Z. Feng, and B.J. Trock et al. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades Eur Urol 61 2012 1019
2. M.A. Dall'Era, P.C. Albertsen, and C. Bangma et al. Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 2012 976
3. P.A. Ganz, J.M. Barry, and W. Burke et al. NIH State-of-the-Science Conference Statement: role of active surveillance in the management of men with localized prostate cancer NIH Consens State Sci Statements 28 2011 1
4. M. Van Hemelrijck, A. Wigertz, and F. Sandin et al. Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0 Int J Epidemiol 42 2013 956
5. A. Berglund, H. Garmo, and C. Tishelman et al. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden J Urol 185 2011 833
6. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis J Natl Cancer Inst 101 2009 878
7. H.B. Carter, A. Kettermann, and C. Warlick et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience J Urol 178 2007 2359
8. L. Klotz, L. Zhang, and A. Lam et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
9. M.A. Dall'Era, B.R. Konety, and J.E. Cowan et al. Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664
10. R.C. van den Bergh, H. Vasarainen, and H.G. van der Poel et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study BJU Int 105 2010 956
11. R.K. Berglund, T.A. Masterson, and K.C. Vora et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964
12. M.S. Soloway, C.T. Soloway, and A. Eldefrawy et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment Eur Urol 58 2010 831
13. L.M. Wong, D.E. Neal, and R.B. Johnston et al. International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy Br J Cancer 107 2012 1467
14. S. Sfoungaristos, and P. Perimenis PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer Can Urol Assoc J 6 2012 46
15. K.S. Tseng, P. Landis, and J.I. Epstein et al. Risk stratification of men choosing surveillance for low risk prostate cancer J Urol 183 2010 1779
16. G. Ploussard, A. de la Taille, and S. Terry et al. Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance Urol Oncol 31 2013 1060
17. B. Gershman, D.M. Dahl, and A.F. Olumi et al. Smaller prostate gland size and older age predict Gleason score upgrading Urol Oncol 31 2013 1033
18. K.L. Schwartz, S.M. Alibhai, and G. Tomlinson et al. Continued undertreatment of older men with localized prostate cancer Urology 62 2003 860
19. T.J. Daskivich, K. Chamie, and L. Kwan et al. Comorbidity and competing risks for mortality in men with prostate cancer Cancer 117 2011 4642
20. A.R. Patel, and J.S. Jones Optimal biopsy strategies for the diagnosis and staging of prostate cancer Curr Opin Urol 19 2009 232
21. E.T. Ruijter, C.A. van de Kaa, and J.A. Schalken et al. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications J Pathol 180 1996 295
22. B.J. Linder, I. Frank, and E.C. Umbreit et al. Standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates Int J Urol 20 2013 860
23. R.H. Shapiro, and P.A. Johnstone Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance Urology 80 2012 661
24. S. Loeb, H.B. Carter, and S.I. Berndt et al. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare J Urol 189 2013 867
25. J.J. Tosoian, S. Loeb, and Z. Feng et al. Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer J Urol 188 2012 1131
26. H.A. Vargas, O. Akin, and A. Afaq et al. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer J Urol 188 2012 1732
27. P. Stattin, E. Holmberg, and J.E. Johansson et al. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study J Natl Cancer Inst 102 2010 950
28. R.A. Godtman, E. Holmberg, and A. Khatami et al. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Goteborg randomised population-based prostate cancer screening trial Eur Urol 63 2013 101
29. J.R. Rider, F. Sandin, and O. Andren et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study Eur Urol 63 2013 88
30. L. Egevad Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images Urology 57 2001 291